Published Medical Neuronal Survival Post-Injury Drug can be applied to the injury site of the spinal cord, and improves neuronal survival by inhibiting the post-injury aggregation of α-synuclein. By University of California, Los Angeles
Published Medical Drugs for Protein Misfolding Drug applicable to a broad range of protein misfolding diseases like Alzheimer's and Parkinson's Diseases. Prevents formation of new aggregates and breaks pre-formed aggregates By University of California, Los Angeles
Published Medical Proteopathic Seed Transmission Specific molecular pathway can be inhibited by small molecules to stop proteopathic tau seed transmission. Therapeutic strategy is applicable across multiple proteopathic diseases. By University of California, Los Angeles
Published Medical 3D-ExoQuant: Exosome Analysis Early and non-invasive detection of surface biomarkers present on exosomes and extracellular vesicles. Allows non-invasive detection of AD biomarkers from brain-derived exosomes. By University of California, Los Angeles
Published Medical Molecular Tweezers The molecule inhibits the principal cause, not symptom, of AD by disaggregating pre-existing Aβ40 and Aβ42 protein fibrils. The tweezer is non-toxic at concentrations up to 200 μM. By University of California, Los Angeles
